Pulmonary Embolism: A Practical Guide for the Busy Clinician.
Biomarkers
Chronic thromboembolic pulmonary hypertension
Deep venous thrombosis
Echocardiography
Pulmonary embolism
Thrombolysis
Venous thromboembolism
Journal
Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
entrez:
7
6
2020
pubmed:
7
6
2020
medline:
21
10
2020
Statut:
ppublish
Résumé
Acute pulmonary embolism (PE) is the third most common acute cardiovascular condition, and its prevalence increases over time. D-dimer has a very high negative predictive value, and if normal levels of D-dimer are detected, the diagnosis of PE is very unlikely. The final diagnosis should be confirmed by computed tomographic scan. However, echocardiography is the most available, bedside, low-cost, diagnostic procedure for patients with PE. Risk stratification is of utmost importance and is mainly based on hemodynamic status of the patient. Patients with PE and hemodynamic stability require further risk assessment, based on clinical symptoms, imaging, and circulating biomarkers.
Identifiants
pubmed: 32503755
pii: S1551-7136(20)30022-2
doi: 10.1016/j.hfc.2020.03.004
pii:
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
317-330Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.